Sign in to view content

Five-Year Outcomes After Initial Aflibercept, Bevacizumab, or Ranibizumab Treatment for Diabetic Macular Edema (Protocol T)

Dante Joseph Pieramici, MD

Video
Published 2020

Related

Longitudinal Total Retinal Fluid Index Assessment in nAMD From the OSPREY Study: A Novel Assessment of Fluid Drying Effect
Sunil Srivastava, MD
On Demand Cases, Courses, and Papers
2020
Delayed and Loss of Follow-Up in Patients Receiving Intravitreal Injections for Diabetic Macular Edema
Jason Hsu, MD
On Demand Cases, Courses, and Papers
2017
Intermittent to Continuous Therapy for Diabetic Macular Edema leads to Reduction in Treatment Frequency and Reduced Retinal Thickness Fluctuations
Seenu M. Hariprasad, MD
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more